Identifying and evaluating field indicators of urogenital schistosomiasis-related morbidity in preschool-aged children

Welcome M Wami, Norman Nausch, Nicholas Midzi, Reggis Gwisai, Takafira Mduluza, Mark Woolhouse, Francisca Mutapi, Welcome M Wami, Norman Nausch, Nicholas Midzi, Reggis Gwisai, Takafira Mduluza, Mark Woolhouse, Francisca Mutapi

Abstract

Background: Several studies have been conducted quantifying the impact of schistosome infections on health and development in school-aged children. In contrast, relatively little is known about morbidity levels in preschool-aged children (≤ 5 years) who have been neglected in terms of schistosome research and control. The aim of this study was to compare the utility of available point-of-care (POC) morbidity diagnostic tools in preschool versus primary school-aged children (6-10 years) and determine markers which can be used in the field to identify and quantify Schistosoma haematobium-related morbidity.

Methods/principal findings: A comparative cross-sectional study was conducted to evaluate the performance of currently available POC morbidity diagnostic tools on Zimbabwean children aged 1-5 years (n=104) and 6-10 years (n=194). Morbidity was determined using the POC diagnostics questionnaire-based reporting of haematuria and dysuria, clinical examination, urinalysis by dipsticks, and urine albumin-to-creatinine ratio (UACR). Attributable fractions were used to quantify the proportion of morbidity attributable to S. haematobium infection. Based on results of attributable fractions, UACR was identified as the most reliable tool for detecting schistosome-related morbidity, followed by dipsticks, visual urine inspection, questionnaires, and lastly clinical examination. The results of urine dipstick attributes showed that proteinuria and microhaematuria accounted for most differences between schistosome egg-positive and negative children (T=-50.1; p<0.001). These observations were consistent in preschool vs. primary school-aged children.

Conclusions/significance: Preschool-aged children in endemic areas can be effectively screened for schistosome-related morbidity using the same currently available diagnostic tools applicable to older children. UACR for detecting albuminuria is recommended as the best choice for rapid assessment of morbidity attributed to S. haematobium infection in children in the field. The use of dipstick microhaematuria and proteinuria as additional indicators of schistosome-related morbidity would improve the estimation of disease burden in young children.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Flowchart indicating number of children…
Fig 1. Flowchart indicating number of children enrolled in the study and excluded from the final analysis.
Fig 2. Non-metric multidimensional scaling (NMDS) ordination…
Fig 2. Non-metric multidimensional scaling (NMDS) ordination in 2-dimensional configurations by sex, age-group and S. haematobium infection status determined using parasitological (A) and serological diagnostic techniques (B).
Subgroup centres are represented by the bigger closed (●), or open (○) points, and the distance between these centres is proportional to the level of dissimilarities between subgroups.
Fig 3. Observed prevalences of morbidity by…
Fig 3. Observed prevalences of morbidity by age group, assessed using different diagnostic tools.
Error bars indicate the 95% confidence intervals.
Fig 4. Estimated proportion of morbidity attributable…
Fig 4. Estimated proportion of morbidity attributable to S. haematobium infection.
(A) Population attributable fraction, (B) Attributable fraction infected.

References

    1. King CH, Dangerfield-Cha M. The unacknowledged impact of chronic schistosomiasis. Chronic Illn. 2008; 4: 65–79. 10.1177/1742395307084407
    1. Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014; 383: 2253–2264. 10.1016/S0140-6736(13)61949-2
    1. World Health Organization. Working to overcome the global impact of neglected tropical diseases First WHO report on neglected tropical diseases. Geneva: World Health Organization; 2010. .
    1. Chen MG, Mott KE. Progress in assessment of morbidity due to Schistosoma haematobium infection. Trop Dis Bull. 1989;86: R1–R36.
    1. van der Werf MJ, de Vlas SJ. Diagnosis of urinary schistosomiasis: a novel approach to compare bladder pathology measured by ultrasound and three methods for hematuria detection. Am J Trop Med Hyg. 2004;71: 98–106.
    1. King CH, Magak P, Salam EA, Ouma JH, Kariuki HC, et al. Measuring morbidity in schistosomiasis mansoni: relationship between image pattern, portal vein diameter and portal branch thickness in large-scale surveys using new WHO coding guidelines for ultrasound in schistosomiasis. Trop Med Int Health. 2003;8: 109–117.
    1. Richter J, Hatz C, Campagne G, Bergquist N, et al. Ultrasound in schistosomiasis A practical guide to the use of standardized ultrasonography for the assessment of schistosomiasis-related morbidity. Geneva: World Health Organization, TDR/STR/SCH/00.1. 2003.
    1. Stothard RJ, Sousa-Figueiredo JC, Simba Khamis I, Garba A, Rollinson D. Urinary schistosomiasis-associated morbidity in schoolchildren detected with urine albumin-to-creatinine ratio (UACR) reagent strips. J Pediatr Urol. 2009;5: 287–291. 10.1016/j.jpurol.2008.09.010
    1. World Health Organization. Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO Expert Committee Technical Report Series number 912. Geneva: World Health Organization; 2002.
    1. World Health Organization. Report of a meeting to review the results of studies on the treatment of Schistosomiasis in preschool-age children. Geneva: World Health Organization; 2011. = 1
    1. Betson M, Sousa-Figueiredo JC, Rowell C, Kabatereine NB, Stothard JR. Intestinal schistosomiasis in mothers and young children in Uganda: investigation of field-applicable markers of bowel morbidity. Am J Trop Med Hyg. 2010;83: 1048–1055. 10.4269/ajtmh.2010.10-0307
    1. Midzi N, Sangweme D, Zinyowera S, Mapingure MP, Brouwer KC, et al. Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe. Trans Roy Soc Trop Med Hyg. 2008;102: 759–766. 10.1016/j.trstmh.2008.03.010
    1. Reilly L, Magkrioti C, Mduluza T, Cavanagh DR, Mutapi F. Effect of treating Schistosoma haematobium infection on Plasmodium falciparum-specific antibody responses. BMC Infect Dis. 2008;8: 158 10.1186/1471-2334-8-158
    1. Mott K, Baltes R, Bambagha J, Baldassini B. Field studies of a reusable polyamide filter for detection of Schistosoma haematobium eggs by urine filtration. Tropenmed Parasitol. 1982;33: 227–228.
    1. Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni . Rev Inst Med Trop Sao Paulo. 1972;14: 397–400.
    1. Wami WM, Nausch N, Bauer K, Midzi N, Gwisai R, et al. Comparing parasitological vs serological determination of Schistosoma haematobium infection prevalence in preschool and primary school-aged children: implications for control programmes. Parasitology. 2014;141: 1962–1970. 10.1017/S0031182014000213
    1. Mutapi F, Ndhlovu PD, Hagan P, Woolhouse ME. A comparison of humoral responses to Schistosoma haematobium in areas with low and high levels of infection. Parasite Immunol. 1997;19: 255–263.
    1. Eknoyan G, Hostetter T, Bakris GL, Hebert L, Levey AS, et al. Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis. 2003;42: 617–622.
    1. Peck JE. Multivariate Analysis for Community Ecologists: Step-by-Step using PC-ORD. Gleneden Beach, Oregon: MjM Software Design; 2010.
    1. Liu IM. Breslow–Day Test Encyclopedia of Biostatistics.2nd ed Chichester: John Wiley & Sons, Ltd; 2005.
    1. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. Philadelphia: Lippincott Williams & Wilkins; 2008.
    1. Sousa-Figueiredo JC, Pleasant J, Day M, Betson M, Rollinson D, et al. Treatment of intestinal schistosomiasis in Ugandan preschool children: best diagnosis, treatment efficacy and side-effects, and an extended praziquantel dosing pole. Int Health. 2010;2: 103–113. 10.1016/j.inhe.2010.02.003
    1. Stothard JR, Sousa-Figueiredo JC, Betson M, Green HK, Seto EYW, et al. Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children. Parasitology. 2011;138: 1593–1606. 10.1017/S0031182011001235
    1. Mutapi F, Rujeni N, Bourke C, Mitchell K, Appleby L, et al. (2011) Schistosoma haematobium treatment in 1–5 year old children: safety and efficacy of the antihelminthic drug praziquantel. PLoS Negl Trop Dis. 2011;5: e1143 10.1371/journal.pntd.0001143
    1. Knopp S, Becker SL, Ingram KJ, Keiser J, Utzinger J. Diagnosis and treatment of schistosomiasis in children in the era of intensified control. Expert Rev Anti Infect Ther. 2013; 11: 1237–1258. 10.1586/14787210.2013.844066
    1. Webster JP, Koukounari A, Lamberton PH, Stothard JR, Fenwick A. Evaluation and application of potential schistosome-associated morbidity markers within large-scale mass chemotherapy programmes. Parasitology. 2009; 136: 1789–1799. 10.1017/S0031182009006350
    1. Sacko M, Magnussen P, Keita AD, Traore MS, Landoure A, et al. Impact of Schistosoma haematobium infection on urinary tract pathology, nutritional status and anaemia in school-aged children in two different endemic areas of the Niger River Basin, Mali. Acta Trop. 2011;120 Suppl 1: S142–150. 10.1016/j.actatropica.2010.12.009
    1. Garba A, Barkiré N, Djibo A, Lamine MS, Sofo B, et al. Schistosomiasis in infants and preschool-aged children: Infection in a single Schistosoma haematobium and a mixed S. haematobium-S. mansoni foci of Niger. Acta Trop. 2010;115: 212–219. 10.1016/j.actatropica.2010.03.005
    1. Rollinson D, Klinger EV, Mgeni AF, Khamis IS, Stothard JR. Urinary schistosomiasis on Zanzibar: application of two novel assays for the detection of excreted albumin and haemoglobin in urine. J Helminthol. 2005;79: 199–206.
    1. Stete K, Krauth SJ, Coulibaly JT, Knopp S, Hattendorf J, et al. Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children. Parasit Vectors. 2012; 5: 298 10.1186/1756-3305-5-298
    1. Lyons B, Stothard R, Rollinson D, Khamis S, Simai KA, et al. A comparison of urinary tract pathology and morbidity in adult populations from endemic and non-endemic zones for urinary schistosomiasis on Unguja Island, Zanzibar. BMC Infect Dis. 2009;9: 189 10.1186/1471-2334-9-189
    1. Guyatt H, Gryseels B, Smith T, Tanner M. Assessing the public health importance of Schistosoma mansoni in different endemic areas: attributable fraction estimates as an approach. Am J Trop Med Hyg. 1995;53: 660–667.
    1. van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 2003;86: 125–139.
    1. Sousa-Figueiredo JC, Basanez MG, Khamis IS, Garba A, Rollinson D, et al. Measuring morbidity associated with urinary schistosomiasis: assessing levels of excreted urine albumin and urinary tract pathologies. PLoS Negl Trop Dis. 2009;3: e526 10.1371/journal.pntd.0000526
    1. King CH, Keating CE, Muruka JF, Ouma JH, Houser H, et al. Urinary tract morbidity in schistosomiasis haematobia: associations with age and intensity of infection in an endemic area of Coast Province, Kenya. Am J Trop Med Hyg. 1998;39: 361–368.
    1. Agnew-Blais J, Carnevale J, Gropper A, Shilika E, Bail R, et al. Schistosomiasis haematobium prevalence and risk factors in a school-age population of peri-urban Lusaka, Zambia. J Trop Pediatr. 2010;56: 247–253. 10.1093/tropej/fmp106
    1. Poole H, Terlouw DJ, Naunje A, Mzembe K, Stanton M, et al. Schistosomiasis in pre-school-age children and their mothers in Chikhwawa district, Malawi with notes on characterization of schistosomes and snails. Parasit Vectors. 2014;7: 153 10.1186/1756-3305-7-153

Source: PubMed

3
Prenumerera